返回 Agenda
LS08 How RWE Affects Decision Making During the COVID-19 Pandemic
Session Chair(s)
Yoshiaki Uyama, PHD, MS, RPH
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Gerald Dal Pan, MD, MHS
FDA, United States
Director, Office of Surveillance and Epidemiology, CDER
Maria Gordillo-Marañon
European Medicines Agency, Netherlands
Chieko Ishiguro, PHD, MPH
National Center for Global Health and Medicine, Japan
Section Chief of Clinical Epidemiology, Department of Data Science